Table 1 Patient characteristics
Variables | Total population (N = 90) | |
|---|---|---|
Gender | Â | |
| Â | Male | 49 (54.4%) |
| Â | Female | 41 (45.6%) |
Age, years | Â | |
| Â | Mean | 65.19 (SD 9.0) |
|  | ≤ 50 | 5 (5.6%) |
|  | 51–60 | 26 (28.9%) |
|  | 61–70 | 31 (34.4%) |
|  | 71–80 | 23 (25.6%) |
| Â | > 80 | 5 (5.6%) |
Years diagnosed with COPD | 8.13 (SD8.11) | |
Disease severity | ||
| Â | GOLDa I | 18 (20.0%) |
| Â | GOLDa II | 60 (66.7%) |
| Â | GOLDa III | 12 (13.3%) |
| Â | FEV1 mean | 1.86 (1.02-3.70) (SD .59) |
| Â | FEV1% pred | 67.0 (36.54-101.22) (SD 14.4) |
Education level b | Â | |
| Â | Low | 13 (14.4%) |
| Â | Medium | 56 (62.3%) |
| Â | High | 21 (23.3%) |
Retired | 46 (51.1%) | |
Paid work | 20 (2.2%) | |
Marital status | Â | |
| Â | Married | 59 (65.6%) |
| Â | Widowed | 8 (8.9%) |
| Â | Divorced | 8 (8.9%) |
| Â | Single | 15 (16.7%) |
Smoking status | Â | |
| Â | Current smoker | 36 (40.0%) |
| Â | Former smoker | 49 (54.4%) |
| Â | Never smoked | 5 (5.6%) |
Medication use | 82 (91.1%) | |
Polypharmacy c | 28 (31.1%) | |
Charlson comorbidity index >1 | 28 (31.1%) | |